Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis ; volume:9 ; number:1 ; day:28 ; month:12 ; year:2021 ; pages:1-24 ; date:2.2022
Rheumatology and therapy ; 9, Heft 1 (28.12.2021), 1-24, 2.2022
- Urheber
-
Truong, Steven L.
McEwan, Tim
Bird, Paul
Lim, Irwin
Saad, Nivene F.
Schachna, Lionel
Taylor, Andrew L.
Robinson, Philip C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-021-00416-7
- URN
-
urn:nbn:de:101:1-2022051221074245927168
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Truong, Steven L.
- McEwan, Tim
- Bird, Paul
- Lim, Irwin
- Saad, Nivene F.
- Schachna, Lionel
- Taylor, Andrew L.
- Robinson, Philip C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
P190: Cardiovascular Disease in Axial Spondyloarthritis